aod9604 clinical trials safety side effects AOD-9604 Profile: What Show Buy AOD-9604 - Fat Metabolism

Inject slowly and steadily

It was developed in the 1990s by researchers at Monash University in Melbourne, Australia, with one goal: isolate the fat-burning portion of growth hormone and deliver those effects without the risks that come with full hGH administration

Instead, AOD 9604 is used to study downstream metabolic processes, particularly adipose tissue signaling and lipid metabolism, without activating the broader endocrine cascade associated with the GH axis

The dose stays consistent while the frequency decreases, followed by 48 weeks off

Retatrutide hits the GLP-1, GIP, and glucagon receptors, which is a complementary mechanism to the lipolytic fragment